Endocrinology Research and Practice
Original Article

Bone Mineral Density in Postmenopausal Women with Endogenous Subclinical Hyperthyroidism

1.

Celal Bayar University, Medical Faculty, Department of Endocrinology, Division of Endocrinology, Manisa, Turkey

2.

Dokuz Eylül University, Medical Faculty, Department of Internal Medicine, Division of Endocrinology and Metabolism, Inciraltı, Izmir, Turkey

3.

Dokuz Eylül University, Medical Faculty, Department of Radiology, Inciraltı, Izmir, Turkey

4.

Dokuz Eylül University, Medical Faculty, Endocrinology Laboratory, Inciraltı, Izmir, Turkey

Endocrinol Res Pract 2000; 4: -
Read: 1329 Published: 21 March 2022
ABSTRACT
The effect of thyrotoxicosis on bone metabolism has been well recognized. Excess thyroid hormone stimulates bone resorption resulting in increased bone turnover which leads to both cortical and trabecular bone loss. This study aimed to evaluate the bone mineral density(BMD) and biochemical markers of bone turnover in 40 postmenopausal women with endogenous subclinical hyperthyroidism due to a hyperactive autonomous thyroid nodule. The levels of serum triidothyronine (T 3), tetraidothyronine (T 4), free T3 (fT3), free T4 (fT4), thyrotropin (TSH), parathyroid hormone(PTH), osteocalcin(OC), calcium(Ca), alkaline phosphatas e (ALP), urine calcium-creatinine and deoxypyridinoline (DPD)-creatinine ratios were evaluated. BMD was measured by quantitative computerized tomography. The results were compared with the age and weight matched controls. BMD was significantly lower in postmenopausal women with endogenous subclinical hyperthyroidism compared to the control group (p< 0.05). Serum ALP and OC levels were higher in the study group than in the controls (p< 0.05). In conclusion endogenous subclinical hyperthyroidism due to an autonomously functioning thyroid nodule is an additional risk factor for osteoporosis in postmenopausal women and it must be treated effectively.
 
EISSN 2822-6135